Phentermine is a sympathomimetic amine [derived from amphetamine] initially approved by the FDA in 1959 for the treatment of obesity. Its usage in the treatment of obesity was considered ideal due to the fact that phentermine suppressed appetite through central modulation of norepinephrine, and peripherally mobilized fat stores through catecholaminergic upregulation. That said, in the …
Data from the CDC (Centers for Disease Control) indicates that approximately 78.6 million adults (34.9%) are clinically obese. Healthcare costs of obesity-related medical conditions such as: cardiovascular disease, cancers, diabetes, and stroke (to name a few) – are thought to exceed $190 billion per year, accounting for over one-fifth of all annual medical expenses in …
According to National Health and Nutrition Examination surveys, over 2 out of 3 adults in the United States are overweight and/or obese. Excessive body weight and/or fat is understood to increase risk for numerous morbidities including: cancer, diabetes, heart disease, hypertension, sleep apnea, and stroke – and that’s just naming a few. Perhaps troubling is …
Estimates suggest that 35% of the entire adult population in the United States is obese; this is more than 1 out of every 3 adults. To make things worse, many of these individuals struggle to fight food cravings and slowed metabolism as a result of psychiatric medications; approximately 1 out of every 5 adults is …
MCTs (Medium Chain Triglycerides) are defined as fatty acids comprised of a 6-12 carbon atom aliphatic tail with a glycerol backbone. The fatty acids derived from MCTs are commonly referenced as “MCFAs” or medium-chain fatty acids. MCT oils are most commonly extracted from coconut oil and palm kernel oil and can take a number of different forms. …
Each year a new Health Survey is conducted throughout England. It takes into account various health conditions and documents the number of individuals that report taking pharmaceutical medications. Results from the latest survey were recently unleashed and showed that 50% of all women and 43% of all men reported taking one prescription drug within the …
In September 2014, the FDA recently approved a new weight loss drug Contrave. This drug is considered the third pharmaceutical treatment for obesity in the United States. Although it probably seems odd to mention a weight loss drug on a mental health website, the fact is that this new drug is a formulation of two …